A Systematic Review of Eczematous Eruptions in Patients Receiving Biologic Therapy

Published: 22-12-2020| Version 1 | DOI: 10.17632/sgwbnf4375.1
Muskaan Sachdeva


The development of biologic agents has revolutionized treatment for immune-mediated inflammatory diseases (IMIDs). An infrequently reported cutaneous complication in the literature is the development of dermatitis during therapy. This systematic review summarizes relevant reports of dermatitis eruptions in patients receiving biologic therapy for IMIDs. The supplemental files are attached here.